Mercola/Midwestern Doctor feature on differentiation, immune visibility, and growth inhibition.

March 2025 deep dive on differentiation, immunity, toxicity mitigation, and chemo potentiation.

Mercola republishes Midwestern Doctor’s D-hematoxylin history for a general audience—extraordinary oncology claims summarized cautiously.

Vigilant Fox popularizes DMSO differentiation science and the hematoxylin combination narrative for a general audience.

Midwestern Doctor retells Tucker’s DMSO–hematoxylin experiments and Ecuador follow-on clinics—extraordinary claims needing scrutiny.

Mercola hosts Midwestern Doctor’s review of DMSO as a chemo penetrant and dose-sparing adjunct.